The company wants to invest RON10 million in expanding its drugstore network and developing its dietary supplements production.
Shareholders decided not to pay out dividends this year and earmark last year’s profit for development, Ropharma said in a press release Tuesday.
The company registered sales of RON413.4 million in 2012, 7.22% higher on the year.
Ropharma operates two plants, in Targu Mures and Chisinau, where it produces dietary supplements and medicines under the brands Activit, Vitalact, Resveravit, Paducel and Glykofit.
The company is owned by Arrow Pharmaceuticals (31.29%), Rimia Investments (14.71%), ADD Pharmaceuticals (17.53%), private pension funds Fondul de Pensii Administrat Privat ING (5.49%) and Fondul de Pensii Privat Allianz-Tiriac (5.53%), other legal entities (4.73%) and natural persons (20.72%). (EUR1=RON4.3224)